Supply Chain Intelligence

AC Immune SA Supply Chain

ACIU supply chain intelligence for AC Immune SA: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

ACIU ·Last updated 2026-09-13 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

9Suppliers
23Customers
1Debt Items
20Related Chains

Source-Backed Evidence Depth

AC Immune SA (ACIU) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

34Total relationships
2Distinct source URLs
7High confidence
0.716Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

AC Immune SA Suppliers

TickerNameConfidenceEvidence
JANSSEN-PHARMACEUTICALS-INC JANSSEN-PHARMACEUTICALS-INC 92% We are in a partnership with Janssen to develop and commercialize therapeutic anti-Tau active immunotherapies for the treatment of AD and potentially other tauopathies.
LANTHEUS-HOLDINGS-INC LANTHEUS-HOLDINGS-INC 92% We also have a diagnostic partnership with Lantheus for compounds, which bind pathological Tau for use as a PET tracer.
LLY Eli Lilly and Company 92% Reciprocal relationship from LLY graph: Reciprocal relationship from ACIU graph: ave achieved and our goal of a close working relationship with the regulatory agencies, in particular the FDA and the …
LLY Eli Lilly and Company 92% ave achieved and our goal of a close working relationship with the regulatory agencies, in particular the FDA and the EMA, are intended to facilitate expeditious execution through the regulatory appr…
TAKEDA-PHARMACEUTICALS-USA-INC TAKEDA-PHARMACEUTICALS-USA-INC 92% In May 2024, we entered into a worldwide option and license agreement with Takeda for our active immunotherapies targeting Abeta, including ACI-24.060.
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from ACIU graph: ave achieved and our goal of a close working relationship with the regulatory agencies, in particular the FDA and the …
JNJ Johnson & Johnson 72% ave achieved and our goal of a close working relationship with the regulatory agencies, in particular the FDA and the EMA, are intended to facilitate expeditious execution through the regulatory appr…
LNTH Lantheus Holdings, Inc. 72% Reciprocal relationship from LNTH graph: Item 1A. “Risk Factors” of this Form 10-K for information regarding certain risks associated with our raw materials and supply arrangements. Manufacturing The…
TAK Takeda Pharmaceutical Company Limited 72% Reciprocal relationship from TAK graph: 16,363 ) Reclassification adjustments to profit or (loss) 9,118 16,150 16,363 Before tax effects — — — Tax effects — — — Changes in fair value of financial ass…

AC Immune SA Customers

TickerNameConfidenceEvidence
JNJ Johnson & Johnson 72% scussed below). Further, the Civil Monetary Penalties Law imposes penalties against any person or entity that, among other things, is determined to have presented or caused to be presented a claim to…
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from ACIU graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ACIU graph: Reciprocal relationship from JNJ grap…
LLY Eli Lilly and Company 72% Reciprocal relationship from LLY graph: Reciprocal relationship from ACIU graph: Reciprocal relationship from LLY graph: Reciprocal relationship from ACIU graph: Reciprocal relationship from LLY grap…
LLY Eli Lilly and Company 72% scussed below). Further, the Civil Monetary Penalties Law imposes penalties against any person or entity that, among other things, is determined to have presented or caused to be presented a claim to…
LNTH Lantheus Holdings, Inc. 72% opean Union have imposed certain sanctions against Russia. The invasion of Ukraine and the retaliatory measures that have been taken, or could be taken in the future, by the United States, NATO, and …
LNTH Lantheus Holdings, Inc. 72% Reciprocal relationship from LNTH graph: Item 1A. “Risk Factors” of this Form 10-K for information regarding certain risks associated with our raw materials and supply arrangements. Manufacturing The…
SNYNF Sanofi 72% n penetrant small molecule inhibitors of NLRP3 inflammasome activation for the treatment of PD. In February 2023, the Company announced that it had been awarded a new grant totaling USD 0.5 (CHF 0.4)…
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from ACIU graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from ACIU graph: Reciprocal relationship from SNYN…
ABIOGEN-MERCK-GROUP ABIOGEN-MERCK-GROUP 62% ate coverage against potential liabilities. In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws, regulations or permitting requ…
AC-IMMUNE-USA-INC AC-IMMUNE-USA-INC 62% scussed below). Further, the Civil Monetary Penalties Law imposes penalties against any person or entity that, among other things, is determined to have presented or caused to be presented a claim to…
CGEN Compugen Ltd. 62% Reciprocal relationship from CGEN graph: Reciprocal relationship from ACIU graph: Reciprocal relationship from CGEN graph: Reciprocal relationship from ACIU graph: Reciprocal relationship from CGEN g…
COGENCY-GLOBAL-INC COGENCY-GLOBAL-INC 62% scussed below). Further, the Civil Monetary Penalties Law imposes penalties against any person or entity that, among other things, is determined to have presented or caused to be presented a claim to…
JANSSEN-PHARMACEUTICALS-INC JANSSEN-PHARMACEUTICALS-INC 62% ndidates with desired cerebrospinal fluid exposure and selectivity for pathological aggregated Tau. These will be broadly developed in Tau-dependent neurodegenerative diseases by Lilly. Lilly is resp…
JOHNSON-LANTHEUS-HOLDINGS-INC JOHNSON-LANTHEUS-HOLDINGS-INC 62% opean Union have imposed certain sanctions against Russia. The invasion of Ukraine and the retaliatory measures that have been taken, or could be taken in the future, by the United States, NATO, and …
LAUSANNE-SWITZERLAND-EXECUTIVE-OFFICERS-ANDREA-P LAUSANNE-SWITZERLAND-EXECUTIVE-OFFICERS-ANDREA-P 62% n penetrant small molecule inhibitors of NLRP3 inflammasome activation for the treatment of PD. In February 2023, the Company announced that it had been awarded a new grant totaling USD 0.5 (CHF 0.4)…
LILLY-JANSSEN-PHARMACEUTICALS-INC LILLY-JANSSEN-PHARMACEUTICALS-INC 62% opean Union have imposed certain sanctions against Russia. The invasion of Ukraine and the retaliatory measures that have been taken, or could be taken in the future, by the United States, NATO, and …
LMI-TAKEDA-PHARMACEUTICALS-USA-INC LMI-TAKEDA-PHARMACEUTICALS-USA-INC 62% opean Union have imposed certain sanctions against Russia. The invasion of Ukraine and the retaliatory measures that have been taken, or could be taken in the future, by the United States, NATO, and …
MERCK-GROUP MERCK-GROUP 62% ate coverage against potential liabilities. In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws, regulations or permitting requ…
MRK Merck & Co., Inc. 62% Reciprocal relationship from MRK graph: Reciprocal relationship from ACIU graph: ate coverage against potential liabilities. In addition, we may incur substantial costs in order to comply with curren…
ROCHE-GROUP ROCHE-GROUP 62% scussed below). Further, the Civil Monetary Penalties Law imposes penalties against any person or entity that, among other things, is determined to have presented or caused to be presented a claim to…
SYMRISE-AG SYMRISE-AG 62% n penetrant small molecule inhibitors of NLRP3 inflammasome activation for the treatment of PD. In February 2023, the Company announced that it had been awarded a new grant totaling USD 0.5 (CHF 0.4)…
TAK Takeda Pharmaceutical Company Limited 62% Reciprocal relationship from TAK graph: Reciprocal relationship from ACIU graph: Reciprocal relationship from TAK graph: Reciprocal relationship from ACIU graph: Reciprocal relationship from TAK grap…
TAKEDA-PHARMACEUTICALS-USA-INC TAKEDA-PHARMACEUTICALS-USA-INC 62% ent. Tau-PET imaging agent – 2014 agreement with Life Molecular Imaging (LMI) In May 2014 (as amended in June 2022), we entered into an agreement, our first diagnostic partnership, with LMI, the form…

AC Immune SA Debt Obligations

InstrumentDescriptionConfidenceEvidence
ACIU-DEBT Debt stack $5.5M 90% Market cache reports total debt of $5.5M.

AC Immune SA Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for AC Immune SA.

AC Immune SA Ownership

HolderNameConfidenceEvidence
ACIU-OWNER-BVF-INC-IL BVF INC/IL 90% 13F overlay lists BVF INC/IL as top holder; 47 tracked holders.

AC Immune SA Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
BNR Burning Rock Biotech Limited 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2
FHTX Foghorn Therapeutics Inc. 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
SVA Sinovac Biotech Ltd. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
DAWN Day One Biopharmaceuticals Inc 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
AXSM Axsome Therapeutics, Inc. 100.00 2
AORT Artivion, Inc. 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
BLLN BillionToOne, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
Browse supply chain intel →

See the full supply chain map, all relationships, and real-time alerts for AC Immune SA.

Unlock full ACIU data — View plans →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map
🔐
ACIU
Unlock ACIU Supply Chain Data
Verified relationships include:
JANSSEN-PHARMACEUTICALS-INCJANSSEN-PHARMACEUTICALS-INCSupplier92%
LANTHEUS-HOLDINGS-INCLANTHEUS-HOLDINGS-INCSupplier92%
JNJJohnson & JohnsonCustomer72%
JNJJohnson & JohnsonCustomer72%
+30 more relationships locked
Subscribe — View plans →
Already a subscriber? Sign in →